Buscar
-
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, n° 12, pp. 1981-1990, 2022-10-26)Article de revue -
Alopecia areata: Recent advances and emerging therapies
(Annales de Dermatologie et de Venereologie. vol. 149, pp. 222-227, 2022-06-23)Article de revue -
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
(Cancer Immunology, Immunotherapy. vol. 71, n° 11, pp. 2609-2618, 2022-11)Article de revue -
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study
(Digestive and Liver Disease. vol. 55, pp. 61-68, 2022-08-16)Article de revue -
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study
(Journal of Autoimmunity. vol. 132, pp. 102868, 2022-07-20)Article de revue -
Diagnostic et prise en charge des bactériémies liées au cathéter d'hémodialyse : 10 ans après les dernières recommandations
(Nephrologie et Therapeutique. vol. 18, n° 2, pp. 80-88, 2022-01-13)Article de revue -
Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosus
(Joint Bone Spine. vol. 89, n° 3, pp. 105311, 2022-03)Article de revue -
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
(European Journal of Cancer. vol. 172, pp. 85-95, 2022-06-24)Article de revue -
Serum lactate and acute mesenteric ischaemia: An observational, controlled multicentre study
(Anaesthesia Critical Care and Pain Medicine. vol. 41, n° 6, pp. 101141, 2022-12)Article de revue -
ribeiro
(Infectious Diseases Now. vol. 52, n° 3, pp. 154-159, 2022-02-13)Article de revue